Xbiome

About:

Xbiome is a developer of microbial pharmaceuticals designed to treat microecological intestinal disorders.

Website: https://xbiome.cn/

Twitter/X: xbiome1

Top Investors: Legend Capital, Sky9 Capital, Gaorong Capital, Primavera Capital Group, Alwin Capital

Description:

Xbiome is the first AI pharmaceutical company in China that specializes in intestinal micro-ecology. It is based on intestinal micro-ecology and relies on AI technology to accurately and personally manage the gut health of 1.3 billion people. The company uses artificial intelligence to analyze patient and donor intestinal (gut) flora to more quickly develop effective pharmaceuticals.